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High-resolution spatial mapping of changes in
the neurochemical proﬁle after focal ischemia
in mice
Malte F. Alfa,b*, Hongxia Leia,c, Carole Berthetd, Lorenz Hirtd,
Rolf Gruettera,c,e and Vladimir Mlynarika
After ischemic stroke, the ischemic damage to brain tissue evolves over time and with an uneven spatial distribution.
Early irreversible changes occur in the ischemic core, whereas, in the penumbra, which receives more collateral
blood ﬂow, the damage is more mild and delayed. A better characterization of the penumbra, irreversibly damaged
and healthy tissues is needed to understand the mechanisms involved in tissue death. MRSI is a powerful tool for this
task if the scan time can be decreased whilst maintaining high sensitivity. Therefore, we made improvements to a 1H
MRSI protocol to study middle cerebral artery occlusion in mice. The spatial distribution of changes in the neuro-
chemical proﬁle was investigated, with an effective spatial resolution of 1.4mL, applying the protocol on a 14.1-T
magnet. The acquired maps included the difﬁcult-to-separate glutamate and glutamine resonances and, to our
knowledge, the ﬁrst mapping of metabolites g-aminobutyric acid and glutathione in vivo, within a metabolite mea-
surement time of 45min. The maps were in excellent agreement with ﬁndings from single-voxel spectroscopy and
offer spatial information at a scan time acceptable for most animal models. The metabolites measured differed with
respect to the temporal evolution of their concentrations and the localization of these changes. Speciﬁcally, lactate
and N-acetylaspartate concentration changes largely overlapped with the T2-hyperintense region visualized with
MRI, whereas changes in cholines and glutathione affected the entire middle cerebral artery territory. Glutamine
maps showed elevated levels in the ischemic striatum until 8h after reperfusion, and until 24h in cortical tissue, in-
dicating differences in excitotoxic effects and secondary energy failure in these tissue types. Copyright © 2011 John
Wiley & Sons, Ltd.
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INTRODUCTION
Studies of brain metabolism under transient ischemia are essen-
tial to obtain an understanding of the mechanisms leading to tis-
sue death. The focal model of middle cerebral artery occlusion
(MCAO) is very useful for the longitudinal examination of the
effects of ischemia in both directly affected tissue (ischemic core
and penumbra) and more distant regions in the brain, simulating
the clinical situation in which tissue viability and its rescuing po-
tential should be assessed. So far, MRS studies of MCAO in vivo
have been limited to either single-voxel spectroscopy [e.g. refs.
(1,2)] or MRSI with a relatively coarse spatial resolution and re-
stricted spectral information (3,4); most MRSI studies to date
have only quantiﬁed a few metabolites, speciﬁcally N-acetylas-
partate (NAA), total creatine (tCr), lactate (Lac), total choline
(tCho) and the sum of glutamate (Glu) and glutamine (Gln). 1H
MRSI in rodent brain, especially in mice, suffers from intrinsically
low sensitivity and therefore very long measurement times. Us-
ing instruments that operate at lower magnetic ﬁeld strengths,
extremely long acquisition times are necessary to achieve a suf-
ﬁcient signal-to-noise ratio (SNR) and, even then, the spectral
resolution allows for the quantiﬁcation of only a limited number
of metabolites. With the exception of 13C MRS studies in rats
(5,6), MRS was unsuitable to address questions concerning the
importance of glutamatergic metabolism and the role of astro-
cytes in ischemia. High-ﬁeld MRSI studies of mouse brain have
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been shown to be feasible despite other challenges, such as in-
creased ﬁeld inhomogeneity. A study using LASER-MRSI (7) on
a vertical bore magnet at 17.6T yielded quantiﬁcations of a
slightly larger set of metabolites, namely NAA+NAAG (i.e. NAA+
N-acetylaspartylglutamate), tCr and tCho, taurine (Tau) and a
combined Glu+Gln value; van der Zijden et al. (8) published
one-dimensional MRSI rat data recorded with a 11.74-T magnet,
also including myo-inositol.
Some methodological efforts to speed up the measurements
have been made over time, such as techniques based on
steady-state free precession (9), the use of spiral trajectories
(10) or sensitivity encoding (11). These new techniques can
shorten the total measurement time, but they do not provide
sufﬁcient SNR for a very small voxel size. In addition, they may
cause problems at the high ﬁeld strengths used here (14.1Tesla),
in particular because of the necessary spectral width. Comparative
studies have shown that standard MRSI (i.e. the use of one TR per
point in k-space), despite its very long acquisition time, is still a
very good choice because of its high sensitivity over time (12).
It is therefore useful to follow this acquisition scheme as closely
as possible whilst tailoring the method to the (e.g. temporal)
needs of the model to be studied and the set-up to be used.
Therefore, our aim was to implement an optimized protocol
with k-space-weighted acquisition and ultra-short TE at very high
magnetic ﬁeld strength to measure the spatial distribution of the
neurochemical proﬁle after transient ischemia in mice within a
reasonable measurement time. The study was intended to
validate and extend the ﬁndings of a previously performed
single-voxel spectroscopy study (1), investigating the feasibility
of identifying potential markers speciﬁc to the ischemic core or
penumbra in brain tissue.
MATERIALS AND METHODS
Animal protocols
All experiments were conducted according to federal and local
ethical guidelines, and the protocol was approved by the local
regulatory body. In order to compare with previously published
single-voxel MRS measurements (1), an identical protocol was
used to induce ischemia and animals were studied at the same
time points of 3, 8 and 24h after reperfusion. Speciﬁcally, the is-
chemia protocol consisted of 30min of ﬁlament-induced tran-
sient MCAO, followed by MR studies at 3, 8 and 24h after
reperfusion from the induced ischemic insults. Seven male ICR-
CD1 mice (8weeks old; 294g; Charles River, L’Arbresle, France)
were used in this study. They were anesthetized and kept under
a face mask at 1.5–2% isoﬂurane in a 30%–70% mixture of O2
and NO2 during surgery. MCAO was induced with an 11-mm, sil-
icone-coated 8–0 nylon ﬁlament (Doccol Co., Redlands, CA, USA)
that was inserted via the left common carotid artery into the in-
ternal carotid artery and advanced to occlude the origin of the
middle cerebral artery (MCA). Reperfusion was initiated after 30
min when the ﬁlament was removed. Success of the procedure
was monitored as regional cerebral blood ﬂow, which was mea-
sured with laser-Doppler ﬂowmetry (Periﬂux 5000, Perimed,
Stockholm, Sweden) at about 1mm posterior and 6mm lateral
to the left from the bregma. Six of seven animals fulﬁlled the cri-
teria to be included in the study, i.e. regional cerebral blood ﬂow
of <20% of the baseline during ischemia and regional cerebral
blood ﬂow of >50% of the baseline after reperfusion. The body
temperature was controlled throughout the procedure and
maintained at 370.5C with a temperature-controlled heating
pad (FHC Inc., Bowdoinham, ME, USA) with feedback from a rec-
tal probe. Buprenorphine (0.025mg/kg) was administered subcu-
taneously as an analgesic at the end of surgery.
Immediately after waking up, animals were housed in a cage
with ﬂoor heating at 34C where their body temperature fell to
31.80.6C. During the time in the magnet (i.e. approximately
3–4.5h, 8–9.5h and 24–25.5h after ischemic onset), warm water
was circulated around the animals to maintain their body tem-
perature at 361C, together with the regulation of their
breathing rate by maintenance under 1.5–2% isoﬂurane. In be-
tween measurements, the animals were allowed to wake up
andwere placed back in their cage. To evaluate some of the effects
of anesthesia and body temperature and for comparison with the
single-voxel spectroscopy data, ﬁve healthy mice (29–36g) were
measured once as a control group.
MRSI of the ischemic brain
We used a horizontal 14.1-T magnet with a 26-cm bore (Magnex
Scientiﬁc, Abingdon, Oxfordshire, UK), 12-cm inner-diameter gra-
dient (400mT/m in 200ms, minimized eddy currents) and sec-
ond-order shim coils with maximum strengths of Z2=5.310–2
mT/cm2, YZ=XZ=1.210–1mT/cm2, XY=4.510–2mT/cm2 and
X2Y2=4.210–2mT/cm2 (Varian/Magnex Scientiﬁc), controlled
via a DirectDrive console (Varian Inc., Palo Alto, CA, USA). A geo-
metrically decoupled home-built quadrature surface coil (inner
diameter, 12mm) was used as radiofrequency transceiver.
For each MRSI measurement, ﬁrst, multislice T2-weighted (TR=
4000ms, TEeff=52ms, four scans) images with a slice thickness of
0.6mm were acquired with a fast spin-echo multislice method
(13) to position the volume of interest (VOI) for the subsequent
MRSI measurement and to detect abnormal T2-hyperintense sig-
nals, i.e. ischemic edema [ref. (1) and references cited therein]. A
1.5-mm-thick coronally oriented VOI of 4mm6mm was se-
lected for excitation at 0.4mm anterior to the bregma, covering
the striatum bilaterally and extending almost to the skull. The
echo planar version of FASTMAP was used for ﬁrst- and sec-
ond-order corrections of the static magnetic ﬁeld in the VOI, as
described by Gruetter and Tkác (14).
For MRSI, we adopted an accelerated k-space acquisition
scheme with a circular sampling window and acquisition weight-
ing with a relatively ﬂat two-dimensional Hamming ﬁlter cen-
tered at the middle of the k space (15), deﬁned by the equation:
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where a=0.9 and N is the matrix size. The SPECIAL (SPin ECho full
Intensity Acquired Localized spectroscopy) technique (16,17)
was used with TE=2.8ms and variably weighted repetition times
which were calculated from the weighting function and the T1
values of the metabolites (an average T1 of about 1500ms at
14.1T) and water (T1 of about 2000ms), respectively (18,19).
The maximum TR at the k-space center was 2500ms for metabo-
lites and 1600ms for water. These settings were used to acquire
a 3232 data matrix cover of a 19mm19mm ﬁeld of view in
the coronal plane.
The corners of k space were zero ﬁlled and data were multi-
plied with another Hamming-shaped ﬁlter during post-processing
so that the total ﬁltering corresponded to the standard
Hamming ﬁlter with a=0.54. The resulting effective full width
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at half-maximum voxel size was therefore 1.4mL. Outer volume
saturation and variable power and optimized relaxation delay
(VAPOR) water suppression were used during metabolite acquisi-
tion. The acquisition time was 45min for the metabolites and 30
min for the water reference. The MRS protocol was tested exten-
sively on water and metabolite phantoms to assess localization
accuracy and spectral quality prior to measurements on animals
in vivo (data not shown).
Data quantiﬁcation and statistics
All data were processed using a home-written MATLAB code.
This processing included the above-mentioned zero ﬁlling and
ﬁltering, as well as Fourier transformation in the spatial and spec-
tral domains. Quantiﬁcation and metabolite assignment were
performed using LCModel, version 6.2-0X (20). We assumed
80% brain water content as in previous studies, e.g. ref. (21). Ab-
solute metabolite concentrations were adjusted for the use of
different variable TRs for water and metabolites. With regard to
macromolecules, our model allows for the total intensity of mac-
romolecular signals to be changed, e.g. in edematous tissue.
The center of the excited volume generally showed better SNR
than its borders. In particular, the corner voxels often showed rela-
tively low spectral quality leading to incorrect LCModel ﬁtting. Most
of the spectra in these voxels could be ﬁtted using manual settings
of the LCModel parameters ‘DEGPPM’ and ‘SDDEGP’, which control
the ﬁrst-order phase correction and its standard deviation of the
expectation value, respectively. DEGPPM was set to match the
actual ﬁrst-order phase distortions within a range of degrees that
LCModel also uses with standard settings, and SDDEGP was in-
creased slightly from its standard value of 2.5 to a maximum of
3.5. Voxels in which quantiﬁcation failed and/or the SNR was too
low (<5) were excluded from region of interest (ROI) analysis.
Metabolite maps were overlaid with T2 images for ROI deﬁnition,
as in Fig. 2. Concentrations were averaged over the voxels
contained in an ROI for each animal, and then over animals to
obtain group values. Error propagation was taken into account.
Two-tailed Student’s t-tests were performed for statistical analy-
sis; paired two-tailed t-tests were used to compare contralateral
and ischemic hemisphere regions. The values in the Results
section show the meanstandard error of the mean (SEM).
RESULTS
Data quality
Field homogeneities could be improved inside the shimmed
volume using FASTMAP. The shim currents calculated by
FASTMAP never exceeded their hardware limits and resulted
in water linewidths of 253Hz for the whole excited volume.
The water linewidth in individual MRSI voxels was as low as
10.2Hz in the center of the ﬁeld of view, and the SNR for
the highest metabolite peak was up to 17.
Spectra of individual voxels allowed for the quantiﬁcation of 15
metabolites [alanine, creatine, phosphocreatine, g-aminobutryric
acid (GABA), Gln, Glu, glutathione (GSH), myo-inositol, Lac, NAA,
NAAG, Tau, ascorbate, glucose and tCho] plus macromolecules
with a Cramér–Rao lower bound (CRLB) of less than 20%; the
resulting concentrations were within error ranges from previous
single-voxel 1H MRS [ref. (1) and Table 1]. Some of these metabo-
lites (alanine, ascorbate and glucose) could not be quantiﬁed
with sufﬁcient accuracy in voxels near the borders of the VOI,
and were therefore excluded from further analysis and discus-
sion. This may be explained by both the very small voxel size
and the fact that the borders of the VOI were very close to the
skull, where one would expect local magnetic ﬁeld inhomogene-
ities that cannot be completely compensated for. In addition,
creatine and phosphocreatine, as well as NAA+NAAG, were trea-
ted as tCr and total NAA, respectively, as their distinction was
possible only in the best quality spectra in the centre of the
VOI. Figure 1 shows examples of spectra from healthy and ische-
mic striatum and the deeper lying hypothalamic region. Even the
latter voxel lying far from the receiver coil has an SNR of 12.
Control group
Metabolite maps of healthy animals showed characteristic
regional concentration differences. These features included high
striatal Tau (12.50.5mmol/g, meanSEM), considerably higher
concentrations of cortical NAA (9.60.5mmol/g) and Glu (10.7
0.9mmol/g), when compared with other structures (Table 1), and
high GABA (3.50.3mmol/g) in the area in which the VOI cov-
ered some hypothalamic tissue. These characteristic features
were consistent with ﬁndings from localized spectroscopy (21).
Lac was measured bilaterally in striatum, where its mean concen-
tration was 5.90.6mmol/g. tCr was almost uniformly distributed
with a concentration of 7.30.2mmol/g.
Transient ischemia
The transient ischemia model consistently induced increased in-
tensities in the observed T2-weighted images at 8h in the target
hemisphere, particularly in striatum, as in the previous study by
Lei et al. (1) using the same model. At 24h, almost the entire
striatum and parts of the overlying cortex displayed T2-hyperin-
tensities in all animals (Fig. 2).
Table 1. Striatal metabolite concentrations other than lactate were the same in healthy controls and in the contralateral striatum
(mean of the three time points measured) in animals after transient ischemia; values from control animals of the same strain
reported in the single-voxel 1H MRS study by Lei et al. (1) are given for comparison. Numbers represent concentrationsstandard
error of the mean (SEM) in mmol/g
Site N-Acetylaspartate Taurine Glutamate γ-Aminobutryric acid Lactate
MCAO contralateral 6.30.2 12.60.5 7.80.2 2.20.2 3.20.3a
Healthy control 6.40.2 12.50.5 7.70.3 2.20.1 5.90.6
Lei et al. (1) 6.70.4 12.91.1 7.30.7 2.30.4 5.61.7
MCAO, middle cerebral artery occlusion.
aDifferent from healthy control at p<0.0001.
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With the exception of Lac, the right striatum in animals with left
MCAO showed metabolite concentrations almost identical to
those in the control group (Table 1), independent of the time at
which they were measured. Relative to the control group values,
Lac was signiﬁcantly (p<0.0001) reduced to 3.20.3mmol/g
in the right striatum, without signiﬁcant temporal differences
(all p>0.1).
We differentiated between two regions in the ipsilateral hemi-
sphere (Fig. 2), one of which was located centrally in the subcor-
tical MCAO territory overlapping with the T2-hyperintense
region, whereas the other covered its edge. The results are
displayed in Fig. 3. Lac concentrations in both regions devel-
oped in a parallel fashion and were increased signiﬁcantly at all
measurements (all p<0.02) compared with contralateral stria-
tum. Interestingly, the rise in Lac levels was much less pro-
nounced in cortical tissue, which is clearly visible in the maps
at 3 and 24h (Fig. 4).
Figure 2. Positioning of MRSI volume and regions of interest (ROIs). Top
row: T2-weighted coronal images at 24h after transient ischemia contrib-
uting to the MRSI signal. Intensity changes can be seen in the middle ce-
rebral artery occlusion (MCAO) region on the right-hand side of the
images. Bottom: overlay of the corresponding N-acetylaspartate (NAA)
map and indication of the following ROIs: 1, ischemic core; 2, penumbra;
3, cortical penumbra; 4, hypothalamus. The spectra in Fig. 1A–C are taken
from voxels in regions 1, 2 and 3, respectively.
Figure 1. Example spectra taken from LCModel analysis from the positions
indicated in the topmost map, i.e. from voxels of 1.4-mL volume each, taken
at 24h after reperfusion. The topmost map shows raw (i.e. no processing
by LCModel, such as phase correction, etc.; 0.2–5.0ppm) spectra. (A)
(corresponding to position A on the map) Spectrum from the nonischemic
(contralateral) striatum. (B) Voxel from region overlying the hypothalamus.
Note the relatively large GABA peaks. (C) Ischemic striatum. Lactate remains
as the only signiﬁcantly increased metabolite, glutamine has returned to
normal values and most other metabolite concentrations are decreased.
Arrows indicate differences relative to healthy striatum. Ala, alanine; GABA,
g-aminobutryric acid; Gln, glutamine; Glu, glutamate; GSH, glutathione; Ins,
myo-inositol; Lac, lactate; NAA, N-acetylaspartate; Tau, taurine; tCho, total
choline; tCr, total creatine.
Figure 3. Temporal evolution of lactate concentrations in the center
and periphery of the middle cerebral artery occlusion (MCAO) territory
and contralateral side. Lactate concentration in control animals is given
as reference. Note that contralateral lactate is decreased in ischemic ani-
mals relative to controls because of hypothermia. Error bars represent
standard error of the mean (SEM).
M. F. ALF ET AL.
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Large concentration changes in the ischemic striatum were
observed for most quantiﬁable components of the neurochemi-
cal proﬁle, e.g. NAA, Tau and Glu (Figs 1 and 5). The extent of the
decrease in NAA in the region developing edema did not corre-
late (p>0.6) with the increase in Lac in the same region for indi-
vidual animals. tCr (6.70.5, 5.61.3 and 4.60.7mmol/g from
consecutive measurements at the three different time points)
and GABA (1.20.4, 1.00.3 and 0.70.3mmol/g, respectively)
showed a temporal decreasing pattern similar to that of NAA
and Tau in Fig. 5. The behavior of GSH was similar to that of
Glu in that the drop compared with the contralateral side was
not signiﬁcantly different at different time points (GSH concen-
trations of 2.00.3 versus 0.90.3mmol/g in contralateral versus
ipsilateral striatum, p<0.0001). In this respect, the MRSI results
differed slightly from those reported by single-voxel MRS (1).
GSH and cholines were decreased in the entire MCA territory (i.e.
most of the respective hemisphere, Fig. 4), whereas changes in
Lac, NAA, Glu and GABA were more restricted to the site of T2
hyperintensity.
In addition, the spatial maps of selected metabolites visualized
the fact that metabolite concentrations differed considerably
within the ischemic lesion territory. Single MRSI voxels displayed
Lac concentrations that were twofold higher than the average is-
chemic striatal Lac level. Gln showed a unique temporal and spa-
tial pattern. Although, in healthy control animals, no voxel in the
entire MRSI map showed Gln concentrations higher than 4mmol/
g, this metabolite was increased signiﬁcantly in the striatum and
cortex of the hemisphere affected by transient ischemia (all p<
0.05) at 3 and 8h. The concentration peaked at 8h (7.50.3m
mol/g in striatum, 8.61.4mmol/g in cortex, see Fig. 6) and
returned to a normal level in striatum at 24h, whilst remaining
signiﬁcantly increased in cortex (p<0.01).
Acetate could be detected in ischemic core and penumbra,
but with a relatively large CRLB, which made meaningful quanti-
ﬁcation impossible. Acetate was not detectable in other regions.
Figure 4. Metabolite maps overlaid on the corresponding anatomical images after 3h (A) and 24h (B); color scale in mmol/g. The maps represent the
volume of interest (VOI) as shown in Fig. 2. Typical spatial patterns can be observed in the contralateral hemisphere, i.e. on the left-hand side, such as
high cortical glutamate (Glu) and high striatal taurine (Tau); in addition, the g-aminobutryric acid (GABA) concentration is high in the region overlapping
the hypothalamus. Gln, glutamine; GSH, glutathione; Lac, lactate; NAA, N-acetylaspartate; tCho, total choline.
Figure 5. Temporal evolution of the concentration of N-acetylaspartate
(NAA), taurine (Tau), g-aminobutryric acid (GABA), glutamate (Glu)
and glutathione (GSH) in the striatal ischemic core. These values
corresponded well to those reported in Lei et al. (1). Values for GSH were
slightly above those from single-voxel spectroscopy. All changes are sig-
niﬁcantly different from zero (at least p<0.05, see text for details). Error
bars represent the standard error of the mean (SEM) of the percentage
change relative to the contralateral side, taking the errors of both the
compared means into account.
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DISCUSSION
The optimization of the sensitivity per unit time on a high-end
machine yielded metabolite maps of both excellent spatial reso-
lution and spectral quantiﬁcation. To our knowledge, this study
is the ﬁrst to provide 1H spectroscopic imaging maps of GABA
and GSH, and also one of the few to map Glu and Gln separately
at high spatial resolution. Our acquisition time was reduced by
almost 50% when compared with a nonweighted full k-space
sampling. As Hamming ﬁltering was already a necessary part of
the previous implementation of this method (17), spatial resolu-
tion suffers only slightly from the circular window imposed in ad-
dition to the weighting. In addition, SNR is only reduced by less
than 10%. Further improvement of the method would be possi-
ble; in particular, the implementation of a volume coil and paral-
lel imaging would lead to an improved and more homogeneous
SNR and a shorter measurement time. The current acquisition
time is 45min for metabolites and an additional 30min for the
water proﬁle if absolute quantiﬁcation is to be performed. Al-
though this seemed suitable for the animal model investigated
in this study, it may still be too long for other purposes. One re-
striction that must be faced using SPECIAL is the need to acquire
an even number of averages per point in k-space, because of its
image-selective in vivo spectroscopy element. However, in
experiments with a surface coil used as a transceiver, the SNR
of SPECIAL is inherently better compared with standard point re-
solved spectroscopy because of the B1-insensitive (adiabatic)
slice selection in the horizontal plane.
The short TE of 2.8ms provides another improvement in SNR,
makes T2 weighting negligible and is useful in the quantiﬁcation
of metabolites giving J-coupled multiplets.
Another potential concern related to the acquisition time is
animal movement. As animals were anesthetized and ﬁxed with
ear pins and a bite bar, the effect of motion in MRSI should, in
general, be similar to that of single-voxel spectroscopy.
The metabolite concentrations measured are comparable
with those measured by single-voxel 1H spectroscopy (1,21).
The Lac concentration in the control striatum is relatively high
(5.90.6mmol/g), which is typical for the ICR-CD1 mouse strain;
Lei et al. (1) determined it to be 5.61.7mmol/g. It is known that
T1, T2 and water content change in ischemic brain tissue (22,23).
Extrapolating from the results in the literature, it is reasonable to
assume an increase in water T1 of about 20% for a measurement
at 14.1T, 24h after 30min of MCAO, given the formation of ische-
mic edema. With regard to the water scaling of metabolite con-
centrations, a higher water content would lead to lower
metabolite concentration estimates, whereas an increase in T1
has an opposite effect. Taken together, this can account for the
underestimation of water-scaled metabolite concentrations by
up to 5% with the ultrashort-echo-time MRSI protocol used in
this study.
Our ﬁnding that GSH is decreased in the entire post-ischemic
MCA territory is different from the results of a recently published
two-photon microscopy study (24) that reported increased pen-
umbral GSH levels.
Bragin et al. (24) used ﬂuorescent staining with monochlor-
obimane. This staining method is known to cause a temporary in-
crease in GSH (25). Although the GSH–monochlorobimane
complex is cleared efﬁciently from healthy tissue, its efﬂux might
be impaired in the metabolically challenged penumbra, because
the efﬂux is dependent on ATP consumption (25). Taking this to-
gether with the choice of different ROIs in our study, we believe
that this may be the best explanation for these seemingly con-
tradictory ﬁndings.
As the GSH level depends on the concentration of its precursors
and is indicative of tissue redox status, may be more sensitive than
ascorbic acid (26) and is mostly localized in astrocytes (27), which
are more resistant to ischemia than neurons (28,29), it is theoret-
ically a very goodmarker for tissue that is still viable but affected by
ischemic stress. However, we found GSH to be decreased through-
out theMCA territory already at 3h after reperfusion, withoutmuch
further temporal development from there, andwithout clear differ-
ences between the edematous region with altered T2 at 24h and
the surrounding tissue. Studies with even higher sensitivity, spe-
ciﬁcally for GSH, are needed to conﬁrm this observation.
Astrocytes are also likely to play a major role in the effects un-
derlying the Gln distributions observed. They are less affected by
excitotoxicity than neurons (29) and continue to take up Glu at a
slower rate during ischemia, although this requires ATP, and pro-
ceed with Gln synthesis even at decreased neuronal metabolism
(30). In a recent single-voxel MRS study, we showed Gln to be an
early and sensitive marker of transient cerebral ischemia in a
mouse model of transient ischemic attack without lesion devel-
opment (31). Gln synthesized during ischemia starts to be re-
leased on reperfusion, resulting in an increased extracellular
concentration for at least 120min (5); therefore, we must be care-
ful in interpreting our ﬁndings of elevated Gln concentrations at
3 and 8h, as they may reﬂect astrocytic accumulation and/or in-
creased extracellular levels. At 24h, Gln in the ischemic core has
returned to its baseline level, probably indicating astrocytic
death, and thus the end of Glu uptake and Gln synthesis. Cortical
Gln remains increased even at 24h, which can be explained by at
least part of the astrocytes still being intact, accumulating Gln.
The concentration of Glu did not decrease further over time
after reperfusion in our study; therefore, we believe that gluta-
matergic excitotoxic effects have worn off at 3h after reperfusion
or before.
The different metabolic response of astrocytes and neurons to
ischemia is also underlined by the lack of correlation between re-
gional changes in Lac and NAA. The reduction in Lac in the contra-
lateral hemisphere, however, is possibly a result of hypothermia in-
duced by ischemia prior to the MR measurement and subsequent
warming in the magnet, as hypothermia is known to slow down
Lac formation (32). Håberg et al. (33) did not observe any
changes in contralateral Lac formation with 13C MRS in rats
ex vivo after 30min of MCAO, but they also did not observe hy-
pothermia in ischemic rats. We also observed altered (less) food
uptake in ischemic mice, which could, via altered blood glucose,
be a further explanation for this ﬁnding. Generally, the Lac
Figure 6. Temporal development of glutamine (Gln) concentrations in
ischemic striatum and cortex and on the contralateral side. Although
striatal Gln returns to baseline concentrations at 24h, cortical Gln follows
a different time course and is still elevated at 24h relative to the contra-
lateral side. Error bars indicate the standard error of the mean (SEM).
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concentration showed a larger variance than other metabolites
between animals, probably because of its greater dependence
on body temperature and anesthesia.
With regard to acetate, its content in normal tissue is too low to
be detectable; therefore, the fact that acetate was detected con-
sistently on all maps in the ischemic regions with concentrations
sufﬁciently large to be identiﬁed by LCModel indicates that it is
indeed increased after cerebral ischemia. This observation is con-
sistent with our preliminary results from a similar model using lo-
calized spectroscopy (34). The accumulation of acetate could be
explained by either a reduction in astrocytic acetate metabolism,
but unimpaired acetate transport via the monocarboxylate trans-
porter-1 (35), or hydrolysis of NAA (36). Acetate metabolism after
ischemia remains to be studied further, as it could be an optional
marker for the identiﬁcation of ischemic insult regions.
CONCLUSIONS
We have implemented a method with very high sensitivity per
time to map 12 components of the neurochemical proﬁle of is-
chemia in mice. This was performed on a relatively large VOI, en-
abling the mapping of even deep brain structures, such as the
hypothalamus. Our results conﬁrm and extend those of a previ-
ous single-voxel study. The ﬁrst mappings of GSH concentration
in vivo indicate that GSH is reduced in both ischemic core and
penumbra, as opposed to recent in vitro ﬁndings. Our observa-
tions on Gln and acetate are in line with results emphasizing
the special role of astrocytes in ischemia.
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